- JP-listed companies
- Cash flow
(4586) Cash flow
Market cap
¥6.6B
P/E ratio
Medrex develops new pharmaceuticals using proprietary skin-patch delivery technology that improves drug effectiveness and reduces side effects.
| 2014/12 | 2015/12 | 2016/12 | 2017/12 | 2018/12 | 2019/12 | 2020/12 | 2021/12 | 2022/12 | 2023/12 | 2024/12 | 2025/12 | |
| Depreciation & amortization | 52 | 76 | 58 | 59 | 40 | 40 | 56 | 60 | 46 | 46 | 38 | 14 |
| Cash from operations | -932 | -789 | -1,215 | -854 | -1,261 | -1,547 | -985 | -924 | -1,073 | -914 | -803 | -888 |
| Capital expenditures | -110 | -39 | -7 | -50 | -42 | -253 | -39 | -3 | -2 | -1 | -0 | -83 |
| Cash from investing | -120 | -44 | 410 | -661 | 569 | -252 | -5 | -3 | -2 | -1 | -3 | -83 |
| Repurchases of common stock | - | - | - | - | - | - | - | - | - | - | - | - |
| Repayments of term debt | -99 | - | - | - | - | - | - | - | - | - | - | - |
| Cash from financing | -99 | 114 | 1,386 | - | 1,362 | 1,415 | 1,394 | 816 | 356 | 1,639 | 1,067 | 745 |